BioCryst Pharma (BCRX) Tops Q2 EPS by 1c; Sees Increase in Net Operating Cash
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/22/2026
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Meta’s new Class C stock to keep Zuckerberg in California, fund AI spending spree
- Oil hits five-month high as Houthi attacks stoke supply fears
- Meta beats Q3 estimates, approves new nonvoting share class as AI spending surges
- Tesla stock up as automotive gross margin improves, free cash flow turns positive
| BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) | Delayed: 7.78 +0.03 (0.39%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.75 | 52 Week High | $10.98 | |||
| Open | $7.78 | 52 Week Low | $1.63 | |||
| Day High | $7.88 | P/E | N/A | |||
| Day Low | $7.66 | EPS | $-0.68 | |||
| Volume | 4,805,393 | |||||
